全文获取类型
收费全文 | 15114篇 |
免费 | 1480篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 537篇 |
妇产科学 | 266篇 |
基础医学 | 1861篇 |
口腔科学 | 348篇 |
临床医学 | 1793篇 |
内科学 | 2848篇 |
皮肤病学 | 174篇 |
神经病学 | 1409篇 |
特种医学 | 478篇 |
外科学 | 2666篇 |
综合类 | 437篇 |
一般理论 | 35篇 |
预防医学 | 1290篇 |
眼科学 | 267篇 |
药学 | 1131篇 |
中国医学 | 8篇 |
肿瘤学 | 957篇 |
出版年
2021年 | 320篇 |
2020年 | 174篇 |
2019年 | 289篇 |
2018年 | 335篇 |
2017年 | 249篇 |
2016年 | 254篇 |
2015年 | 311篇 |
2014年 | 504篇 |
2013年 | 627篇 |
2012年 | 808篇 |
2011年 | 811篇 |
2010年 | 422篇 |
2009年 | 423篇 |
2008年 | 711篇 |
2007年 | 748篇 |
2006年 | 678篇 |
2005年 | 712篇 |
2004年 | 645篇 |
2003年 | 607篇 |
2002年 | 554篇 |
2001年 | 428篇 |
2000年 | 382篇 |
1999年 | 366篇 |
1998年 | 159篇 |
1997年 | 109篇 |
1996年 | 130篇 |
1995年 | 120篇 |
1994年 | 110篇 |
1993年 | 116篇 |
1992年 | 301篇 |
1991年 | 273篇 |
1990年 | 267篇 |
1989年 | 260篇 |
1988年 | 251篇 |
1987年 | 263篇 |
1986年 | 251篇 |
1985年 | 233篇 |
1984年 | 180篇 |
1983年 | 156篇 |
1982年 | 144篇 |
1981年 | 113篇 |
1980年 | 96篇 |
1979年 | 139篇 |
1978年 | 103篇 |
1976年 | 108篇 |
1975年 | 98篇 |
1974年 | 102篇 |
1973年 | 126篇 |
1972年 | 111篇 |
1971年 | 87篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
2.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
3.
Julia Thornton Snider Jesse Sussell Mahlet Gizaw Tebeka Alicia Gonzalez Joshua T. Cohen Peter Neumann 《Value in health》2019,22(3):332-339
Background
Payers frequently rely on budget impact model (BIM) results to help determine drug coverage policy and its effect on their bottom line. It is unclear whether BIMs typically overestimate or underestimate real-world budget impact.Objective
We examined how different modeling assumptions influenced the results of 6 BIMs from the Institute for Clinical and Economic Review (ICER).Study Design
Retrospective analysis of pharmaceutical sales data.Methods
From ICER reports issued before 2016, we collected estimates of 3 BIM outputs: aggregate therapy cost (ie, cost to treat the patient population with a particular therapy), therapy uptake, and price. We compared these against real-world estimates that we generated using drug sales data. We considered 2 classes of BIM estimates: those forecasting future uptake of new agents, which assumed “unmanaged uptake,” and those describing the contemporaneous market state (ie, estimates of current, managed uptake and budget impact for compounds already on the market).Results
Differences between ICER's estimates and our own were largest for forecasted studies. Here, ICER's uptake estimates exceeded real-world estimates by factors ranging from 7.4 (sacubitril/valsartan) to 54 (hepatitis C treatments). The “unmanaged uptake” assumption (removed from ICER's approach in 2017) yields large deviations between BIM estimates and real-world consumption. Nevertheless, in some cases, ICER's BIMs that relied on current market estimates also deviated substantially from real-world sales data.Conclusions
This study highlights challenges with forecasting budget impact. In particular, assumptions about uptake and data source selection can greatly influence the accuracy of results. 相似文献4.
5.
ABSTRACT Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis. However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases. Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases. 相似文献
6.
7.
8.
A new range of stand magnifiers has been released by the COIL company in the United Kingdom. Examination of these magnifiers reveals that they fail to deliver the rated magnifications labelled prominently on the appliances, as a result of the manufacturer's conformance with the requirements of the German DIN standard and the use of back vertex power (F'v) rather than equivalent dioptric power (Fm) of the magnifier. In this study we provide information on the optometric parameters of these new stand magnifiers that will assist the more accurate specification of improvements in vision expected from their use. 相似文献
9.
J. M. Johnston P. Grondziowski R. M. Windisch R. A. Eder L. Lytle 《Acta diabetologica》1995,32(4):213-216
A feasibility study was undertaken to evaluate laboratory phlebotomists performing bedside glucose monitoring (BGM) over a
3-month period on a medical and surgical floor. Specific questions included: feasibility of providing testing on a 24-h basis,
accuracy, appropriate utilization, effect on patient care, and an analysis of cost. In all, 1975 tests were performed on 114
patients. BGM results were within 15% of the laboratory's result 97% of the time. Patient and physician satisfaction was high.
Although the cost of BGM is slightly higher than a laboratory glucose test, its use appeared to reduce the length of hospital
stay by 0.47 days. Practical information on initiating a highly successful BGM program is provided. 相似文献
10.
Sixty-three mallards were fed one of ten poly(methyl methacrylate) based synthetic grit formulations containing varying concentrations of a proposed wildlife contraceptive (nicarbazin), plasticizer (acetyl tributylcitrate) and/or cross-linking agent (1,4-butanediol diacrylate). Release characteristics of the contraceptive agent were monitored for the purpose of developing a contraceptive formulation for control of pest waterfowl in urban settings. The addition of plasticizer increased the erosion rate (t(1/2)=0.97-2.85 days), cross-linking the polymer matrix slightly decreased the erosion rate (t(1/2)=4.45-5.05 days) and increasing the concentration of the contraceptive agent increased the erosion rate (t(1/2)=3.3 and 9.9 days at 60% and 7.5% active ingredient, respectively). The larger and smaller grit pieces had longer half lives at 11.0 and 11.6 days, respectively while the mid sized grit had a half life of 4.95 days. Control grit had a half life of 12.7 days based on weight loss. Analysis of blood and feces for monitoring release from the grit and approximate indirect plasma levels of the active ingredient proved feasible. 相似文献